Hjem › Kronisk myelogen leukemi › New York › New York City
Kliniske studier for Kronisk myelogen leukemi i New York City, NY
11 studier for Kronisk myelogen leukemi søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Cord Blood Transplant in Adults With Blood Cancers
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center, New York
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RekruttererFase 2
- Columbia University Medical Center New York Presbyterian, New York
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- og 3 flere
Asciminib Roll-over Study
RekruttererFase 4
- Memorial Sloan Kettering, New York
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
RekruttererObservasjonsstudie
- Pfizer New York, New York
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- Memorial Sloan Kettering, New York
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Kronisk myelogen leukemi-studier i andre byer
- Houston, TX18 studier
- Seattle, WA11 studier
- Philadelphia, PA6 studier
- Portland, OR6 studier
- Birmingham, AL6 studier
- Detroit, MI6 studier
- Baldwin Park, CA6 studier
- Chicago, IL6 studier
- Durham, NC5 studier
- Nashville, TN5 studier
- Boston, MA5 studier
- Baltimore, MD5 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.